How To Solve The Pricing Problem: Turnover Cap Or Mortgage Repayments?
Companies need to offer new pricing models if they want stay in business and keep innovating, and payers too need to think outside the box if they want to deliver innovative new treatments to patients.
You may also be interested in...
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.